Key result
Elevated Lp(a) levels were more prevalent in children with possible familial hypercholesterolemia compared to those with definite FH.
Observational (n=1,418)
Answers are grounded in this paper and cite their sources.
Elevated Lp(a) is common in children with familial and polygenic hypercholesterolemia and contributes significantly to LDL-C levels, highlighting the need for early targeted evaluation.
Aims Lipoprotein(a) [Lp(a)] is a significant genetic risk factor for cardiovascular disease (CVD). Extremely high Lp(a) levels (153mg/dL), affecting about 1 in 100 individuals, can elevate low-density lipoprotein cholesterol (LDL-C) due to structural similarities between Lp(a) and LDL-C particles. This study assessed the role and impact of Lp(a) on LDL-C in children with hypercholesterolemia, a relationship that remains poorly understood. Methods The study included 1,418 children (median age: 6.34 years) with hypercholesterolemia, identified by universal or cascade familial hypercholesterolemia (FH) screening in Slovenia. Participants were categorized as: 363 (25.6%) with definite FH (pathogenic variants in LDLR/APOB/PCSK9), 1,014 (71.5%) with possible FH (no FH pathogenic variant), and 41 (2.9%) definite non-FH (siblings of definite FH cases without FH pathogenic variant). Results Elevated Lp(a) levels (>30 mg/dL) were found in 25.1% of definite FH and 34.9% of possible FH cases (p=0.003). In definite FH, 32.7% of Lp(a) levels contributed to LDL-C levels, and 18.6% of Lp(a) levels contributed to Apolipoprotein B. The Lp(a) component of LDL-C varied widely (0–49.6%) and accounted for 10.3% of LDL-C variability. After adjusting for Lp(a), elevated LDL-C (>3.5 mmol/L) still persisted in 88.4% of definite FH and 30.4% of possible FH children. Conclusions One in four children with FH and one in three children with polygenic hypercholesterolemia have elevated Lp(a) levels, contributing notably to LDL-C levels and ApoB. Modifiable CVD risk factors (elevated LDL-C and obesity) are already present in those children, highlighting the need for early, targeted evaluation and management.
No takes yet. Share an insight, caveat, or question.
Mlinarić et al. (2026) conducted an observational in hypercholesterolemia (n=1,418). Possible familial hypercholesterolemia vs. Definite familial hypercholesterolemia was evaluated on Elevated Lp(a) levels (>30 mg/dL) (p=0.003). Elevated Lp(a) levels were more prevalent in children with possible familial hypercholesterolemia compared to those with definite FH.
Synapse has enriched 10 related papers. Consider them for comparative context: